216 related articles for article (PubMed ID: 18176616)
1. Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin.
Shenoy S; Smith FO
Bone Marrow Transplant; 2008 Jan; 41(2):141-8. PubMed ID: 18176616
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
Giralt S
Curr Hematol Rep; 2005 May; 4(3):200-7. PubMed ID: 15865872
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for myeloid malignancy in children with Fanconi anemia.
Mehta PA; Ileri T; Harris RE; Williams DA; Mo J; Smolarek T; Auerbach AD; Kelly P; Davies SM
Pediatr Blood Cancer; 2007 Jun; 48(7):668-72. PubMed ID: 16609946
[TBL] [Abstract][Full Text] [Related]
5. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
Choi SW; Boxer LA; Pulsipher MA; Roulston D; Hutchinson RJ; Yanik GA; Cooke KR; Ferrara JL; Levine JE
Bone Marrow Transplant; 2005 Mar; 35(5):473-7. PubMed ID: 15640815
[TBL] [Abstract][Full Text] [Related]
6. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson RA
Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
[TBL] [Abstract][Full Text] [Related]
7. Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep.
Woods WG
Pediatr Blood Cancer; 2006 May; 46(5):565-9. PubMed ID: 16261562
[TBL] [Abstract][Full Text] [Related]
8. Second allogeneic stem cell transplantation in myeloid malignancies.
Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
10. Umbilical cord blood transplantation for myeloid malignancies.
Brunstein CG; Baker KS; Wagner JE
Curr Opin Hematol; 2007 Mar; 14(2):162-9. PubMed ID: 17255794
[TBL] [Abstract][Full Text] [Related]
11. Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?
McClune BL; Weisdorf DJ
Curr Opin Hematol; 2010 Mar; 17(2):133-8. PubMed ID: 20071984
[TBL] [Abstract][Full Text] [Related]
12. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic and myeloproliferative disorders in children.
Hasle H
Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
[TBL] [Abstract][Full Text] [Related]
15. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.
Phekoo KJ; Richards MA; Møller H; Schey SA;
Haematologica; 2006 Oct; 91(10):1400-4. PubMed ID: 17018393
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
Giralt S
Curr Hematol Rep; 2004 May; 3(3):165-72. PubMed ID: 15087063
[TBL] [Abstract][Full Text] [Related]
17. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Nevill TJ; Shepherd JD; Sutherland HJ; Abou Mourad YR; Lavoie JC; Barnett MJ; Nantel SH; Toze CL; Hogge DE; Forrest DL; Song KW; Power MM; Nitta JY; Dai Y; Smith CA
Biol Blood Marrow Transplant; 2009 Feb; 15(2):205-13. PubMed ID: 19167680
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
[TBL] [Abstract][Full Text] [Related]
19. [Acute myeloid leukemia].
Tabuchi K
Gan To Kagaku Ryoho; 2007 Feb; 34(2):156-61. PubMed ID: 17301520
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic transplantation for childhood ALL.
Mehta PA; Davies SM
Bone Marrow Transplant; 2008 Jan; 41(2):133-9. PubMed ID: 17994118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
